UBS Group AG

Holdings History for TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI)

Symbol: TMCI on Nasdaq
Investment type: Equity / Common stock, $0.001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$720,126	293,929	+10,580	+3.7%	$2.45	Q4 2025
30 Sep 2025	0%	-0%	$1,901,272	283,349	-94,098	-25%	$6.71	Q3 2025
30 Jun 2025	0%	+0%	$2,219,389	377,447	+16,128	+4.5%	$5.88	Q2 2025
31 Mar 2025	0%	-0%	$3,031,466	361,319	-607,115		$8.39	Q1 2025
31 Dec 2024	0%	+0%	$7,205,149	968,434	+892,456	+1175%	$7.44	Q4 2024
30 Sep 2024	0%	+0%	$440,673	75,978	+35,959	+90%	$5.80	Q3 2024
30 Jun 2024	0%	-0%	$266,126	40,019	-44,684	-53%	$6.65	Q2 2024
31 Mar 2024	0%	+0%	$1,105,374	84,703	+32,904	+64%	$13.05	Q1 2024
31 Dec 2023	0%	+0%	$660,437	51,799	+51,674	+41339%	$12.75	Q4 2023
30 Sep 2023	0%	-0%	$1,639	125	-33,199	-100%	$13.11	Q3 2023
30 Jun 2023	0%	+0%	$852,428	33,324	+19,179	+136%	$25.58	Q2 2023
31 Mar 2023	0%	+0%	$356,313	14,145	+8,039	+132%	$25.19	Q1 2023
31 Dec 2022	0%	+0%	$140,377	6,106	+4,664	+323%	$22.99	Q4 2022
30 Sep 2022	0%	+0%	$32,000	1,442	+737	+105%	$22.19	Q3 2022
30 Jun 2022		0%	$1,000	100	0		$10.00 ^*	Q2 2022
30 Jun 2022	0%	+0%	$10,000	705	+605	+605%	$14.18	Q2 2022
31 Mar 2022	0%	-0%	$2,000	100	-9,435	-99%	$20.00	Q1 2022
31 Dec 2021	0%	+0%	$178,000	9,535	+9,311	+4157%	$18.67	Q4 2021
30 Sep 2021	0%	-0%	$6,000	224	-251	-53%	$26.79	Q3 2021
30 Jun 2021	0%	+0%	$15,000	475	+475	NEW	$31.58	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.